XENE vs NOVT

Comparison between Xenon Pharmaceuticals Inc (XENE, Company) and Novanta Inc (NOVT, Company).

XENE is from the Healthcare sector, while NOVT is from the Technology sector.

5-Year PerformanceXENE has outperformed NOVT, delivering a return of +27.7% compared to +1.3%

XENE vs NOVT - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	XENE(COMPANY)	NOVT(COMPANY)
Market Cap	$5.83B	$5.83B
Max Drawdown	90.43%	46.71%
Sharpe Ratio	1.19	0.61
5Y Beta	0.93	1.60
Industry	Biotechnology	Scientific & Technical Instruments
P/E Ratio	-12.96	108.81
Forward P/E	N/A	8.39
PEG Ratio	-0.32	2.11
5Y EPS CAGR	40.27%	3.84%
Debt to Equity	0.00%	18.41%
Free Cash Flow Yield	-5.27%	1.18%
P/S Ratio	727.44	5.80
P/B Ratio	4.36	4.45

Market Cap

XENE

$5.83B

Winner

NOVT

$5.83B

Max Drawdown

XENE

90.43%

Winner

NOVT

46.71%

Sharpe Ratio

Winner

XENE

1.19

NOVT

0.61

5Y Beta

Winner

XENE

0.93

NOVT

1.60

Industry

XENE

Biotechnology

NOVT

Scientific & Technical Instruments

P/E Ratio

Winner

XENE

-12.96

NOVT

108.81

Forward P/E

XENE

N/A

NOVT

8.39

PEG Ratio

Winner

XENE

-0.32

NOVT

2.11

5Y EPS CAGR

Winner

XENE

40.27%

NOVT

3.84%

Debt to Equity

Winner

XENE

0.00%

NOVT

18.41%

Free Cash Flow Yield

XENE

-5.27%

Winner

NOVT

1.18%

P/S Ratio

XENE

727.44

Winner

NOVT

5.80

P/B Ratio

Winner

XENE

4.36

NOVT

4.45

XENE vs NOVT - Historical Returns

Returns include dividend reinvestment.

Period	XENE	NOVT
1 month	+23.75%	-10.03%
3 months	+9.92%	+28.25%
6 months	+50.45%	+18.97%
1 year	+99.09%	+14.79%
5 years(CAGR)	+27.73%	+1.30%
10 years(CAGR)	+24.65%	+25.61%
Max(CAGR)	+16.66%	+25.84%

Winner

XENE

+23.75%

NOVT

-10.03%

XENE

+9.92%

Winner

NOVT

+28.25%

Winner

XENE

+50.45%

NOVT

+18.97%

Winner

XENE

+99.09%

NOVT

+14.79%

5Y(CAGR)

Winner

XENE

+27.73%

NOVT

+1.30%

10Y(CAGR)

XENE

+24.65%

Winner

NOVT

+25.61%

Max(CAGR)

XENE

+16.66%

Winner

NOVT

+25.84%

XENE vs NOVT - Annual Returns (2014 - 2026)

Returns include dividend reinvestment.

Year	XENE	NOVT
2026	+42.44%	+33.03%
2025	+11.58%	-21.16%
2024	-12.71%	-7.02%
2023	+23.62%	+24.91%
2022	+24.82%	-21.81%
2021	+111.94%	+49.84%
2020	+12.10%	+29.17%
2019	+96.26%	+38.01%
2018	+119.48%	+24.75%
2017	-64.01%	+132.02%
2016	-3.27%	+58.85%
2015	-57.01%	N/A
2014	+88.10%	N/A

XENE vs NOVT Drawdown Comparison

The maximum drawdown for XENE was -90.43%, occurring on Nov 14, 2017. Recovery took 1696 trading sessions.

The maximum drawdown for NOVT was -46.71%, occurring on Nov 20, 2025. This drawdown has not yet recovered.

The current NOVT drawdown is -20.60%.

Rank	XENE	NOVT
#1	-90.43% Jan 8, 2015 - Oct 4, 2021	-46.71% Jul 16, 2024 - Nov 20, 2025
#2	-43.59% Feb 9, 2024 - Mar 9, 2026	-38.60% Nov 4, 2021 - Jun 29, 2023
#3	-34.08% May 9, 2023 - Dec 22, 2023	-34.98% Jul 17, 2023 - Jul 16, 2024
#4	-30.14% Nov 5, 2021 - Aug 4, 2022	-31.80% Feb 13, 2020 - May 20, 2020
#5	-25.87% Nov 11, 2014 - Dec 11, 2014	-27.81% Aug 27, 2018 - Feb 22, 2019
#6	-18.40% Mar 9, 2026 - Jul 7, 2026	-24.96% Jun 28, 2019 - Jan 13, 2020
#7	-17.08% Mar 1, 2023 - May 3, 2023	-19.00% Nov 21, 2017 - Jan 16, 2018
#8	-16.98% Aug 24, 2022 - Feb 13, 2023	-18.56% Jan 26, 2018 - Apr 17, 2018
#9	-11.44% Oct 15, 2021 - Nov 2, 2021	-16.09% Aug 6, 2020 - Oct 9, 2020
#10	-11.09% Dec 11, 2014 - Dec 29, 2014	-15.54% Feb 12, 2021 - Aug 11, 2021
#11	-9.36% Feb 13, 2023 - Mar 1, 2023	-11.81% Jun 5, 2020 - Aug 6, 2020
#12	-8.58% Jan 8, 2024 - Feb 8, 2024	-11.56% Apr 12, 2019 - Jun 18, 2019
#13	-8.27% Aug 10, 2022 - Aug 24, 2022	-11.54% Jun 14, 2018 - Jul 20, 2018
#14	-6.08% Dec 29, 2014 - Jan 7, 2015	-11.40% Jan 5, 2016 - Mar 4, 2016
#15	-4.89% Dec 27, 2023 - Jan 8, 2024	-11.16% Sep 24, 2021 - Oct 22, 2021